Egg Drop Syndrome 76 in a U.S. Broiler Breeder Flock
Abstract
A four-house broiler breeder farm of approximately 35-wk-old hens was diagnosed with egg drop syndrome (EDS'76) utilizing PCR and hemagglutination inhibition (HI) testing. Based on communication with local practitioners, the geographic area near where this flock was located had numerous EDS'76 cases in table egg layers at the time of diagnosis. An egg production drop was seen in the broiler breeder flock over a 7-day period, which prompted an investigation. During this investigation, a significant number of shell-less, wrinkled, and pale eggs were noted, but no increases in mortality or respiratory signs were observed. The disease and subsequent production drops spread horizontally across the farm over a 5-wk period. Production returned to approximately the breed standard egg production 4 wk after initial egg production drop. However, hatching egg utilization continued to be reduced for another 2 wk because of the number of thin-shelled eggs. A similar pattern of drop in egg production and subsequent return was observed in the other houses. No significant lesions were noted in the tissues submitted for histopathology. Differential diagnoses that could cause shell abnormalities and egg production drops were ruled out by submitting appropriate samples for diagnostic investigation. Egg drop syndrome 76 PCR was performed on shell-less eggs and EDS'76 was detected by PCR at two separate laboratories. Subsequently, serum was submitted for HI and positive results were found in each…
How strong is the evidence?
Evidence Hub reads this as a case report, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.
Read the paper
Related studies
- The Matrisome: In Silico Definition and In Vivo Characterization by Proteomics of Normal and Tumor Extracellular Matrices
- The Escherichia coli MG1655 in silico metabolic genotype: Its definition, characteristics, and capabilities
- In silico pharmacology for drug discovery: methods for virtual ligand screening and profiling
- In silico prediction of splice-altering single nucleotide variants in the human genome
- In silico clinical trials: how computer simulation will transform the biomedical industry
- In silico optimization of a guava antimicrobial peptide enables combinatorial exploration for peptide design
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.